As you probably know, Canada is denying hydroxychloroquine-based treatment to the population, except sometimes at a late stage, when it’s mostly ineffective. The only Canadian
May 4, 2021 This article is about the “8th Day Therapy” concept developed by Dr Shankara Chetty from South Africa, who has treated… (46,327)
August 15, 2020 Australian radio host Luke Bona interviewed this August 12 Professor Thomas Borody, from the Centre for Digestive Diseases in Sydney,… (13,400)
September 18, 2021 This interview with Jessica Rose, PhD, covers the question of vaccine safety, as it can be evaluated from actual real… (44,224)
December 21, 2021 In this interview with internationally renowned Dr. Shankara Chetty from South Africa, we discuss the Omicron variant, which is taking… (36,952)
August 19, 2020 The Centre for Digestive Diseases issued today a press release titled “Ivermectin Triple Therapy Protocol for COVID-19 Released to Australian… (7,620)
April 9, 2020 The new study, of which the abstract was released today, was performed at IHU Méditerranée Infection, Marseille, France. A cohort… (1,340)
March 24, 2021 One of the most active analysts during this pandemic regarding the treatment of COVID-19 has been independent researcher Adam Gaertner.… (1,151)
August 25, 2021 We are pleased to present a webinar about a crucial topic: the early treatment of those catching COVID-19, especially with… (11,819)
May 23, 2021 We are pleased to present our interview with Dr Richard Urso, one of America's most prominent frontline doctors. The interview… (667)
November 12, 2021 This is Part 1 of my interview with Dr. Mark McDonald, Medical Doctor and Psychiatrist from California. We discuss the… (6,450)
Greetings and welcome. COVEXIT.com offers you independent global news and policy analysis regarding COVID-19, with emphasis on early treatments.
We are on Spotify and Apple Podcasts! Check our page listing all our podcasts.
We are on Twitter and also on GAB and Mewe.
Bonjour. Nous aurons prochainement du contenu nouveau via Substack. Vous êtes invité à vous y abonner!
